THERAVANCE BIOPHARMA INC filings

SEC filings by THERAVANCE BIOPHARMA INC (ownership)
TypeFiledFilerSubjectShares OwnedPercent Owned
SC 13G2020-06-11ACACIA RESEARCH CORPTheravance Biopharma, Inc.00.0%EDGAR
SC 13G/A2020-03-09BlackRock Inc.Theravance Biopharma, Inc.8,682,67913.9%EDGAR
SC 13D/A2020-02-27GLAXOSMITHKLINE PLCTheravance Biopharma, Inc.9,644,80815.5%EDGAR
SC 13D/A2020-02-18GLAXOSMITHKLINE PLCTheravance Biopharma, Inc.9,644,80815.5%EDGAR
SC 13G/A2020-02-12VANGUARD GROUP INCTheravance Biopharma, Inc.4,003,6027.0%EDGAR
SC 13G/A2020-02-07FMR LLCTheravance Biopharma, Inc.8,524,17315.0%EDGAR
SC 13G/A2020-02-06BlackRock Inc.Theravance Biopharma, Inc.3,829,0796.7%EDGAR
SC 13G2020-01-28WELLINGTON MANAGEMENT GROUP LLPTheravance Biopharma, Inc.3,177,5375.6%EDGAR
SC 13G/A2019-11-08Woodford Investment Management LtdTheravance Biopharma, Inc.429,7700.8%EDGAR
SC 13G2019-10-29Link Fund Solutions LtdTheravance Biopharma, Inc.5,251,3499.3%EDGAR
SC 13D/A2019-04-18GLAXOSMITHKLINE PLCTheravance Biopharma, Inc.9,644,80817.4%EDGAR
SC 13G/A2019-02-14LF Woodford Equity Income FundTheravance Biopharma, Inc.10,592,18919.1%EDGAR
SC 13G/A2019-02-14Woodford Investment Management LtdTheravance Biopharma, Inc.12,316,52922.2%EDGAR
SC 13G/A2019-02-13FMR LLCTheravance Biopharma, Inc.8,336,72615.0%EDGAR
SC 13G/A2019-02-12VANGUARD GROUP INCTheravance Biopharma, Inc.3,980,0607.2%EDGAR
SC 13G/A2019-02-06BlackRock Inc.Theravance Biopharma, Inc.3,863,0767.0%EDGAR
SC 13G/A2018-02-13FMR LLCTheravance Biopharma, Inc.8,139,62015.0%EDGAR
SC 13G/A2018-02-13BAUPOST GROUP LLC/MATheravance Biopharma, Inc.10,179,99618.5%EDGAR
SC 13G/A2018-02-13CF Woodford Equity Income FundTheravance Biopharma, Inc.8,114,94615.0%EDGAR
SC 13G/A2018-02-13Woodford Investment Management LtdTheravance Biopharma, Inc.10,747,10819.9%EDGAR